Global Anti-CD133 Antibody Supply, Demand and Key Producers, 2024-2030

Description

The global Anti-CD133 Antibody market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The industry trend for Anti-CD133 Antibody has seen a rise as it becomes an increasingly important tool in stem cell research and oncology. The antibody's role in identifying and isolating cancer stem cells has implications for the development of novel therapeutics targeting these cells, which are believed to be responsible for tumor recurrence and resistance to treatment. Additionally, the potential for CD133 in regenerative applications is driving the demand for high-quality Anti-CD133 Antibody products. As research progresses and the functions of CD133 in various diseases are further understood, the industry trend for this antibody is expected to continue growing.

Anti-CD133 Antibody is an antibody that specifically binds to CD133, a cell surface protein known as cluster of differentiation 133. CD133 is primarily found on stem cells, including those of the blood and epithelial tissues. This antibody is widely used in research to isolate and study stem cells, particularly in the context of cancer research, where CD133 has been associated with tumor initiating cells. It is also explored for its potential in regenerative medicine and tissue engineering due to CD133's presence on cells with regenerative potential.

This report studies the global Anti-CD133 Antibody demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Anti-CD133 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-CD133 Antibody that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Anti-CD133 Antibody total market, 2019-2030, (USD Million)
Global Anti-CD133 Antibody total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Anti-CD133 Antibody total market, key domestic companies and share, (USD Million)
Global Anti-CD133 Antibody revenue by player and market share 2019-2024, (USD Million)
Global Anti-CD133 Antibody total market by Type, CAGR, 2019-2030, (USD Million)
Global Anti-CD133 Antibody total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Anti-CD133 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BosterBio, GeneTex, ProSci, Bioss, Absolute Antibody, MyBioSource, Biorbyt, Thermo Fisher Scientific and R&D Systems, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-CD133 Antibody market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Anti-CD133 Antibody Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Anti-CD133 Antibody Market, Segmentation by Type
    Monoclonal Antibody
    Polyclonal Antibody

Global Anti-CD133 Antibody Market, Segmentation by Application
    Biotechnology
    Medical
    University
    Others

Companies Profiled:
    BosterBio
    GeneTex
    ProSci
    Bioss
    Absolute Antibody
    MyBioSource
    Biorbyt
    Thermo Fisher Scientific
    R&D Systems
    Novus Biologicals
    BioLegend
    G Biosciences
    Cell Signaling Technology
    RayBiotech
    HUABIO
    Abeomics
    Proteintech Group
    Miltenyi Biotec
    Wuhan Fine Biotech
    NSJ Bioreagents
    Bethyl Laboratories
    OriGene Technologies
    Signalway Antibody
    Abnova
    Bioassay Technology Laboratory
    AAT Bioquest
    Sino Biological
    ProteoGenix

Key Questions Answered
1. How big is the global Anti-CD133 Antibody market?
2. What is the demand of the global Anti-CD133 Antibody market?
3. What is the year over year growth of the global Anti-CD133 Antibody market?
4. What is the total value of the global Anti-CD133 Antibody market?
5. Who are the major players in the global Anti-CD133 Antibody market?

Table of Contents

1 Supply Summary
    1.1 Anti-CD133 Antibody Introduction
    1.2 World Anti-CD133 Antibody Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Anti-CD133 Antibody Total Market by Region (by Headquarter Location)
        1.3.1 World Anti-CD133 Antibody Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Anti-CD133 Antibody Market Size (2019-2030)
        1.3.3 China Anti-CD133 Antibody Market Size (2019-2030)
        1.3.4 Europe Anti-CD133 Antibody Market Size (2019-2030)
        1.3.5 Japan Anti-CD133 Antibody Market Size (2019-2030)
        1.3.6 South Korea Anti-CD133 Antibody Market Size (2019-2030)
        1.3.7 ASEAN Anti-CD133 Antibody Market Size (2019-2030)
        1.3.8 India Anti-CD133 Antibody Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Anti-CD133 Antibody Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Anti-CD133 Antibody Major Market Trends

2 Demand Summary
    2.1 World Anti-CD133 Antibody Consumption Value (2019-2030)
    2.2 World Anti-CD133 Antibody Consumption Value by Region
        2.2.1 World Anti-CD133 Antibody Consumption Value by Region (2019-2024)
        2.2.2 World Anti-CD133 Antibody Consumption Value Forecast by Region (2025-2030)
    2.3 United States Anti-CD133 Antibody Consumption Value (2019-2030)
    2.4 China Anti-CD133 Antibody Consumption Value (2019-2030)
    2.5 Europe Anti-CD133 Antibody Consumption Value (2019-2030)
    2.6 Japan Anti-CD133 Antibody Consumption Value (2019-2030)
    2.7 South Korea Anti-CD133 Antibody Consumption Value (2019-2030)
    2.8 ASEAN Anti-CD133 Antibody Consumption Value (2019-2030)
    2.9 India Anti-CD133 Antibody Consumption Value (2019-2030)

3 World Anti-CD133 Antibody Companies Competitive Analysis
    3.1 World Anti-CD133 Antibody Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Anti-CD133 Antibody Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Anti-CD133 Antibody in 2023
        3.2.3 Global Concentration Ratios (CR8) for Anti-CD133 Antibody in 2023
    3.3 Anti-CD133 Antibody Company Evaluation Quadrant
    3.4 Anti-CD133 Antibody Market: Overall Company Footprint Analysis
        3.4.1 Anti-CD133 Antibody Market: Region Footprint
        3.4.2 Anti-CD133 Antibody Market: Company Product Type Footprint
        3.4.3 Anti-CD133 Antibody Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Anti-CD133 Antibody Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Anti-CD133 Antibody Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Anti-CD133 Antibody Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Anti-CD133 Antibody Consumption Value Comparison
        4.2.1 United States VS China: Anti-CD133 Antibody Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Anti-CD133 Antibody Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Anti-CD133 Antibody Companies and Market Share, 2019-2024
        4.3.1 United States Based Anti-CD133 Antibody Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Anti-CD133 Antibody Revenue, (2019-2024)
    4.4 China Based Companies Anti-CD133 Antibody Revenue and Market Share, 2019-2024
        4.4.1 China Based Anti-CD133 Antibody Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Anti-CD133 Antibody Revenue, (2019-2024)
    4.5 Rest of World Based Anti-CD133 Antibody Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Anti-CD133 Antibody Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Anti-CD133 Antibody Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Anti-CD133 Antibody Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Monoclonal Antibody
        5.2.2 Polyclonal Antibody
    5.3 Market Segment by Type
        5.3.1 World Anti-CD133 Antibody Market Size by Type (2019-2024)
        5.3.2 World Anti-CD133 Antibody Market Size by Type (2025-2030)
        5.3.3 World Anti-CD133 Antibody Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Anti-CD133 Antibody Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Biotechnology
        6.2.2 Medical
        6.2.3 University
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Anti-CD133 Antibody Market Size by Application (2019-2024)
        6.3.2 World Anti-CD133 Antibody Market Size by Application (2025-2030)
        6.3.3 World Anti-CD133 Antibody Market Size by Application (2019-2030)

7 Company Profiles
    7.1 BosterBio
        7.1.1 BosterBio Details
        7.1.2 BosterBio Major Business
        7.1.3 BosterBio Anti-CD133 Antibody Product and Services
        7.1.4 BosterBio Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 BosterBio Recent Developments/Updates
        7.1.6 BosterBio Competitive Strengths & Weaknesses
    7.2 GeneTex
        7.2.1 GeneTex Details
        7.2.2 GeneTex Major Business
        7.2.3 GeneTex Anti-CD133 Antibody Product and Services
        7.2.4 GeneTex Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 GeneTex Recent Developments/Updates
        7.2.6 GeneTex Competitive Strengths & Weaknesses
    7.3 ProSci
        7.3.1 ProSci Details
        7.3.2 ProSci Major Business
        7.3.3 ProSci Anti-CD133 Antibody Product and Services
        7.3.4 ProSci Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 ProSci Recent Developments/Updates
        7.3.6 ProSci Competitive Strengths & Weaknesses
    7.4 Bioss
        7.4.1 Bioss Details
        7.4.2 Bioss Major Business
        7.4.3 Bioss Anti-CD133 Antibody Product and Services
        7.4.4 Bioss Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Bioss Recent Developments/Updates
        7.4.6 Bioss Competitive Strengths & Weaknesses
    7.5 Absolute Antibody
        7.5.1 Absolute Antibody Details
        7.5.2 Absolute Antibody Major Business
        7.5.3 Absolute Antibody Anti-CD133 Antibody Product and Services
        7.5.4 Absolute Antibody Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Absolute Antibody Recent Developments/Updates
        7.5.6 Absolute Antibody Competitive Strengths & Weaknesses
    7.6 MyBioSource
        7.6.1 MyBioSource Details
        7.6.2 MyBioSource Major Business
        7.6.3 MyBioSource Anti-CD133 Antibody Product and Services
        7.6.4 MyBioSource Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 MyBioSource Recent Developments/Updates
        7.6.6 MyBioSource Competitive Strengths & Weaknesses
    7.7 Biorbyt
        7.7.1 Biorbyt Details
        7.7.2 Biorbyt Major Business
        7.7.3 Biorbyt Anti-CD133 Antibody Product and Services
        7.7.4 Biorbyt Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Biorbyt Recent Developments/Updates
        7.7.6 Biorbyt Competitive Strengths & Weaknesses
    7.8 Thermo Fisher Scientific
        7.8.1 Thermo Fisher Scientific Details
        7.8.2 Thermo Fisher Scientific Major Business
        7.8.3 Thermo Fisher Scientific Anti-CD133 Antibody Product and Services
        7.8.4 Thermo Fisher Scientific Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Thermo Fisher Scientific Recent Developments/Updates
        7.8.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.9 R&D Systems
        7.9.1 R&D Systems Details
        7.9.2 R&D Systems Major Business
        7.9.3 R&D Systems Anti-CD133 Antibody Product and Services
        7.9.4 R&D Systems Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 R&D Systems Recent Developments/Updates
        7.9.6 R&D Systems Competitive Strengths & Weaknesses
    7.10 Novus Biologicals
        7.10.1 Novus Biologicals Details
        7.10.2 Novus Biologicals Major Business
        7.10.3 Novus Biologicals Anti-CD133 Antibody Product and Services
        7.10.4 Novus Biologicals Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Novus Biologicals Recent Developments/Updates
        7.10.6 Novus Biologicals Competitive Strengths & Weaknesses
    7.11 BioLegend
        7.11.1 BioLegend Details
        7.11.2 BioLegend Major Business
        7.11.3 BioLegend Anti-CD133 Antibody Product and Services
        7.11.4 BioLegend Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 BioLegend Recent Developments/Updates
        7.11.6 BioLegend Competitive Strengths & Weaknesses
    7.12 G Biosciences
        7.12.1 G Biosciences Details
        7.12.2 G Biosciences Major Business
        7.12.3 G Biosciences Anti-CD133 Antibody Product and Services
        7.12.4 G Biosciences Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 G Biosciences Recent Developments/Updates
        7.12.6 G Biosciences Competitive Strengths & Weaknesses
    7.13 Cell Signaling Technology
        7.13.1 Cell Signaling Technology Details
        7.13.2 Cell Signaling Technology Major Business
        7.13.3 Cell Signaling Technology Anti-CD133 Antibody Product and Services
        7.13.4 Cell Signaling Technology Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Cell Signaling Technology Recent Developments/Updates
        7.13.6 Cell Signaling Technology Competitive Strengths & Weaknesses
    7.14 RayBiotech
        7.14.1 RayBiotech Details
        7.14.2 RayBiotech Major Business
        7.14.3 RayBiotech Anti-CD133 Antibody Product and Services
        7.14.4 RayBiotech Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 RayBiotech Recent Developments/Updates
        7.14.6 RayBiotech Competitive Strengths & Weaknesses
    7.15 HUABIO
        7.15.1 HUABIO Details
        7.15.2 HUABIO Major Business
        7.15.3 HUABIO Anti-CD133 Antibody Product and Services
        7.15.4 HUABIO Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 HUABIO Recent Developments/Updates
        7.15.6 HUABIO Competitive Strengths & Weaknesses
    7.16 Abeomics
        7.16.1 Abeomics Details
        7.16.2 Abeomics Major Business
        7.16.3 Abeomics Anti-CD133 Antibody Product and Services
        7.16.4 Abeomics Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Abeomics Recent Developments/Updates
        7.16.6 Abeomics Competitive Strengths & Weaknesses
    7.17 Proteintech Group
        7.17.1 Proteintech Group Details
        7.17.2 Proteintech Group Major Business
        7.17.3 Proteintech Group Anti-CD133 Antibody Product and Services
        7.17.4 Proteintech Group Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Proteintech Group Recent Developments/Updates
        7.17.6 Proteintech Group Competitive Strengths & Weaknesses
    7.18 Miltenyi Biotec
        7.18.1 Miltenyi Biotec Details
        7.18.2 Miltenyi Biotec Major Business
        7.18.3 Miltenyi Biotec Anti-CD133 Antibody Product and Services
        7.18.4 Miltenyi Biotec Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 Miltenyi Biotec Recent Developments/Updates
        7.18.6 Miltenyi Biotec Competitive Strengths & Weaknesses
    7.19 Wuhan Fine Biotech
        7.19.1 Wuhan Fine Biotech Details
        7.19.2 Wuhan Fine Biotech Major Business
        7.19.3 Wuhan Fine Biotech Anti-CD133 Antibody Product and Services
        7.19.4 Wuhan Fine Biotech Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.19.5 Wuhan Fine Biotech Recent Developments/Updates
        7.19.6 Wuhan Fine Biotech Competitive Strengths & Weaknesses
    7.20 NSJ Bioreagents
        7.20.1 NSJ Bioreagents Details
        7.20.2 NSJ Bioreagents Major Business
        7.20.3 NSJ Bioreagents Anti-CD133 Antibody Product and Services
        7.20.4 NSJ Bioreagents Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.20.5 NSJ Bioreagents Recent Developments/Updates
        7.20.6 NSJ Bioreagents Competitive Strengths & Weaknesses
    7.21 Bethyl Laboratories
        7.21.1 Bethyl Laboratories Details
        7.21.2 Bethyl Laboratories Major Business
        7.21.3 Bethyl Laboratories Anti-CD133 Antibody Product and Services
        7.21.4 Bethyl Laboratories Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.21.5 Bethyl Laboratories Recent Developments/Updates
        7.21.6 Bethyl Laboratories Competitive Strengths & Weaknesses
    7.22 OriGene Technologies
        7.22.1 OriGene Technologies Details
        7.22.2 OriGene Technologies Major Business
        7.22.3 OriGene Technologies Anti-CD133 Antibody Product and Services
        7.22.4 OriGene Technologies Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.22.5 OriGene Technologies Recent Developments/Updates
        7.22.6 OriGene Technologies Competitive Strengths & Weaknesses
    7.23 Signalway Antibody
        7.23.1 Signalway Antibody Details
        7.23.2 Signalway Antibody Major Business
        7.23.3 Signalway Antibody Anti-CD133 Antibody Product and Services
        7.23.4 Signalway Antibody Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.23.5 Signalway Antibody Recent Developments/Updates
        7.23.6 Signalway Antibody Competitive Strengths & Weaknesses
    7.24 Abnova
        7.24.1 Abnova Details
        7.24.2 Abnova Major Business
        7.24.3 Abnova Anti-CD133 Antibody Product and Services
        7.24.4 Abnova Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.24.5 Abnova Recent Developments/Updates
        7.24.6 Abnova Competitive Strengths & Weaknesses
    7.25 Bioassay Technology Laboratory
        7.25.1 Bioassay Technology Laboratory Details
        7.25.2 Bioassay Technology Laboratory Major Business
        7.25.3 Bioassay Technology Laboratory Anti-CD133 Antibody Product and Services
        7.25.4 Bioassay Technology Laboratory Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.25.5 Bioassay Technology Laboratory Recent Developments/Updates
        7.25.6 Bioassay Technology Laboratory Competitive Strengths & Weaknesses
    7.26 AAT Bioquest
        7.26.1 AAT Bioquest Details
        7.26.2 AAT Bioquest Major Business
        7.26.3 AAT Bioquest Anti-CD133 Antibody Product and Services
        7.26.4 AAT Bioquest Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.26.5 AAT Bioquest Recent Developments/Updates
        7.26.6 AAT Bioquest Competitive Strengths & Weaknesses
    7.27 Sino Biological
        7.27.1 Sino Biological Details
        7.27.2 Sino Biological Major Business
        7.27.3 Sino Biological Anti-CD133 Antibody Product and Services
        7.27.4 Sino Biological Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.27.5 Sino Biological Recent Developments/Updates
        7.27.6 Sino Biological Competitive Strengths & Weaknesses
    7.28 ProteoGenix
        7.28.1 ProteoGenix Details
        7.28.2 ProteoGenix Major Business
        7.28.3 ProteoGenix Anti-CD133 Antibody Product and Services
        7.28.4 ProteoGenix Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024)
        7.28.5 ProteoGenix Recent Developments/Updates
        7.28.6 ProteoGenix Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Anti-CD133 Antibody Industry Chain
    8.2 Anti-CD133 Antibody Upstream Analysis
    8.3 Anti-CD133 Antibody Midstream Analysis
    8.4 Anti-CD133 Antibody Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Anti-CD133 Antibody Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Anti-CD133 Antibody Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Anti-CD133 Antibody Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Anti-CD133 Antibody Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Anti-CD133 Antibody Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Anti-CD133 Antibody Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Anti-CD133 Antibody Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Anti-CD133 Antibody Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Anti-CD133 Antibody Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Anti-CD133 Antibody Players in 2023
    Table 12. World Anti-CD133 Antibody Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Anti-CD133 Antibody Company Evaluation Quadrant
    Table 14. Head Office of Key Anti-CD133 Antibody Player
    Table 15. Anti-CD133 Antibody Market: Company Product Type Footprint
    Table 16. Anti-CD133 Antibody Market: Company Product Application Footprint
    Table 17. Anti-CD133 Antibody Mergers & Acquisitions Activity
    Table 18. United States VS China Anti-CD133 Antibody Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Anti-CD133 Antibody Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Anti-CD133 Antibody Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Anti-CD133 Antibody Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Anti-CD133 Antibody Revenue Market Share (2019-2024)
    Table 23. China Based Anti-CD133 Antibody Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Anti-CD133 Antibody Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Anti-CD133 Antibody Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Anti-CD133 Antibody Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Anti-CD133 Antibody Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Anti-CD133 Antibody Revenue Market Share (2019-2024)
    Table 29. World Anti-CD133 Antibody Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Anti-CD133 Antibody Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Anti-CD133 Antibody Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Anti-CD133 Antibody Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Anti-CD133 Antibody Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Anti-CD133 Antibody Market Size by Application (2025-2030) & (USD Million)
    Table 35. BosterBio Basic Information, Area Served and Competitors
    Table 36. BosterBio Major Business
    Table 37. BosterBio Anti-CD133 Antibody Product and Services
    Table 38. BosterBio Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. BosterBio Recent Developments/Updates
    Table 40. BosterBio Competitive Strengths & Weaknesses
    Table 41. GeneTex Basic Information, Area Served and Competitors
    Table 42. GeneTex Major Business
    Table 43. GeneTex Anti-CD133 Antibody Product and Services
    Table 44. GeneTex Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. GeneTex Recent Developments/Updates
    Table 46. GeneTex Competitive Strengths & Weaknesses
    Table 47. ProSci Basic Information, Area Served and Competitors
    Table 48. ProSci Major Business
    Table 49. ProSci Anti-CD133 Antibody Product and Services
    Table 50. ProSci Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. ProSci Recent Developments/Updates
    Table 52. ProSci Competitive Strengths & Weaknesses
    Table 53. Bioss Basic Information, Area Served and Competitors
    Table 54. Bioss Major Business
    Table 55. Bioss Anti-CD133 Antibody Product and Services
    Table 56. Bioss Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Bioss Recent Developments/Updates
    Table 58. Bioss Competitive Strengths & Weaknesses
    Table 59. Absolute Antibody Basic Information, Area Served and Competitors
    Table 60. Absolute Antibody Major Business
    Table 61. Absolute Antibody Anti-CD133 Antibody Product and Services
    Table 62. Absolute Antibody Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Absolute Antibody Recent Developments/Updates
    Table 64. Absolute Antibody Competitive Strengths & Weaknesses
    Table 65. MyBioSource Basic Information, Area Served and Competitors
    Table 66. MyBioSource Major Business
    Table 67. MyBioSource Anti-CD133 Antibody Product and Services
    Table 68. MyBioSource Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. MyBioSource Recent Developments/Updates
    Table 70. MyBioSource Competitive Strengths & Weaknesses
    Table 71. Biorbyt Basic Information, Area Served and Competitors
    Table 72. Biorbyt Major Business
    Table 73. Biorbyt Anti-CD133 Antibody Product and Services
    Table 74. Biorbyt Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Biorbyt Recent Developments/Updates
    Table 76. Biorbyt Competitive Strengths & Weaknesses
    Table 77. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 78. Thermo Fisher Scientific Major Business
    Table 79. Thermo Fisher Scientific Anti-CD133 Antibody Product and Services
    Table 80. Thermo Fisher Scientific Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Thermo Fisher Scientific Recent Developments/Updates
    Table 82. Thermo Fisher Scientific Competitive Strengths & Weaknesses
    Table 83. R&D Systems Basic Information, Area Served and Competitors
    Table 84. R&D Systems Major Business
    Table 85. R&D Systems Anti-CD133 Antibody Product and Services
    Table 86. R&D Systems Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. R&D Systems Recent Developments/Updates
    Table 88. R&D Systems Competitive Strengths & Weaknesses
    Table 89. Novus Biologicals Basic Information, Area Served and Competitors
    Table 90. Novus Biologicals Major Business
    Table 91. Novus Biologicals Anti-CD133 Antibody Product and Services
    Table 92. Novus Biologicals Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Novus Biologicals Recent Developments/Updates
    Table 94. Novus Biologicals Competitive Strengths & Weaknesses
    Table 95. BioLegend Basic Information, Area Served and Competitors
    Table 96. BioLegend Major Business
    Table 97. BioLegend Anti-CD133 Antibody Product and Services
    Table 98. BioLegend Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. BioLegend Recent Developments/Updates
    Table 100. BioLegend Competitive Strengths & Weaknesses
    Table 101. G Biosciences Basic Information, Area Served and Competitors
    Table 102. G Biosciences Major Business
    Table 103. G Biosciences Anti-CD133 Antibody Product and Services
    Table 104. G Biosciences Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. G Biosciences Recent Developments/Updates
    Table 106. G Biosciences Competitive Strengths & Weaknesses
    Table 107. Cell Signaling Technology Basic Information, Area Served and Competitors
    Table 108. Cell Signaling Technology Major Business
    Table 109. Cell Signaling Technology Anti-CD133 Antibody Product and Services
    Table 110. Cell Signaling Technology Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Cell Signaling Technology Recent Developments/Updates
    Table 112. Cell Signaling Technology Competitive Strengths & Weaknesses
    Table 113. RayBiotech Basic Information, Area Served and Competitors
    Table 114. RayBiotech Major Business
    Table 115. RayBiotech Anti-CD133 Antibody Product and Services
    Table 116. RayBiotech Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. RayBiotech Recent Developments/Updates
    Table 118. RayBiotech Competitive Strengths & Weaknesses
    Table 119. HUABIO Basic Information, Area Served and Competitors
    Table 120. HUABIO Major Business
    Table 121. HUABIO Anti-CD133 Antibody Product and Services
    Table 122. HUABIO Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. HUABIO Recent Developments/Updates
    Table 124. HUABIO Competitive Strengths & Weaknesses
    Table 125. Abeomics Basic Information, Area Served and Competitors
    Table 126. Abeomics Major Business
    Table 127. Abeomics Anti-CD133 Antibody Product and Services
    Table 128. Abeomics Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. Abeomics Recent Developments/Updates
    Table 130. Abeomics Competitive Strengths & Weaknesses
    Table 131. Proteintech Group Basic Information, Area Served and Competitors
    Table 132. Proteintech Group Major Business
    Table 133. Proteintech Group Anti-CD133 Antibody Product and Services
    Table 134. Proteintech Group Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 135. Proteintech Group Recent Developments/Updates
    Table 136. Proteintech Group Competitive Strengths & Weaknesses
    Table 137. Miltenyi Biotec Basic Information, Area Served and Competitors
    Table 138. Miltenyi Biotec Major Business
    Table 139. Miltenyi Biotec Anti-CD133 Antibody Product and Services
    Table 140. Miltenyi Biotec Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 141. Miltenyi Biotec Recent Developments/Updates
    Table 142. Miltenyi Biotec Competitive Strengths & Weaknesses
    Table 143. Wuhan Fine Biotech Basic Information, Area Served and Competitors
    Table 144. Wuhan Fine Biotech Major Business
    Table 145. Wuhan Fine Biotech Anti-CD133 Antibody Product and Services
    Table 146. Wuhan Fine Biotech Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 147. Wuhan Fine Biotech Recent Developments/Updates
    Table 148. Wuhan Fine Biotech Competitive Strengths & Weaknesses
    Table 149. NSJ Bioreagents Basic Information, Area Served and Competitors
    Table 150. NSJ Bioreagents Major Business
    Table 151. NSJ Bioreagents Anti-CD133 Antibody Product and Services
    Table 152. NSJ Bioreagents Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 153. NSJ Bioreagents Recent Developments/Updates
    Table 154. NSJ Bioreagents Competitive Strengths & Weaknesses
    Table 155. Bethyl Laboratories Basic Information, Area Served and Competitors
    Table 156. Bethyl Laboratories Major Business
    Table 157. Bethyl Laboratories Anti-CD133 Antibody Product and Services
    Table 158. Bethyl Laboratories Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 159. Bethyl Laboratories Recent Developments/Updates
    Table 160. Bethyl Laboratories Competitive Strengths & Weaknesses
    Table 161. OriGene Technologies Basic Information, Area Served and Competitors
    Table 162. OriGene Technologies Major Business
    Table 163. OriGene Technologies Anti-CD133 Antibody Product and Services
    Table 164. OriGene Technologies Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 165. OriGene Technologies Recent Developments/Updates
    Table 166. OriGene Technologies Competitive Strengths & Weaknesses
    Table 167. Signalway Antibody Basic Information, Area Served and Competitors
    Table 168. Signalway Antibody Major Business
    Table 169. Signalway Antibody Anti-CD133 Antibody Product and Services
    Table 170. Signalway Antibody Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 171. Signalway Antibody Recent Developments/Updates
    Table 172. Signalway Antibody Competitive Strengths & Weaknesses
    Table 173. Abnova Basic Information, Area Served and Competitors
    Table 174. Abnova Major Business
    Table 175. Abnova Anti-CD133 Antibody Product and Services
    Table 176. Abnova Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 177. Abnova Recent Developments/Updates
    Table 178. Abnova Competitive Strengths & Weaknesses
    Table 179. Bioassay Technology Laboratory Basic Information, Area Served and Competitors
    Table 180. Bioassay Technology Laboratory Major Business
    Table 181. Bioassay Technology Laboratory Anti-CD133 Antibody Product and Services
    Table 182. Bioassay Technology Laboratory Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 183. Bioassay Technology Laboratory Recent Developments/Updates
    Table 184. Bioassay Technology Laboratory Competitive Strengths & Weaknesses
    Table 185. AAT Bioquest Basic Information, Area Served and Competitors
    Table 186. AAT Bioquest Major Business
    Table 187. AAT Bioquest Anti-CD133 Antibody Product and Services
    Table 188. AAT Bioquest Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 189. AAT Bioquest Recent Developments/Updates
    Table 190. AAT Bioquest Competitive Strengths & Weaknesses
    Table 191. Sino Biological Basic Information, Area Served and Competitors
    Table 192. Sino Biological Major Business
    Table 193. Sino Biological Anti-CD133 Antibody Product and Services
    Table 194. Sino Biological Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 195. Sino Biological Recent Developments/Updates
    Table 196. ProteoGenix Basic Information, Area Served and Competitors
    Table 197. ProteoGenix Major Business
    Table 198. ProteoGenix Anti-CD133 Antibody Product and Services
    Table 199. ProteoGenix Anti-CD133 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 200. Global Key Players of Anti-CD133 Antibody Upstream (Raw Materials)
    Table 201. Anti-CD133 Antibody Typical Customers
List of Figure
    Figure 1. Anti-CD133 Antibody Picture
    Figure 2. World Anti-CD133 Antibody Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Anti-CD133 Antibody Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Anti-CD133 Antibody Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Anti-CD133 Antibody Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Anti-CD133 Antibody Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Anti-CD133 Antibody Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Anti-CD133 Antibody Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Anti-CD133 Antibody Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Anti-CD133 Antibody Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Anti-CD133 Antibody Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Anti-CD133 Antibody Revenue (2019-2030) & (USD Million)
    Figure 13. Anti-CD133 Antibody Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Anti-CD133 Antibody Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Anti-CD133 Antibody Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Anti-CD133 Antibody Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Anti-CD133 Antibody Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Anti-CD133 Antibody Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Anti-CD133 Antibody Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Anti-CD133 Antibody Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Anti-CD133 Antibody Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Anti-CD133 Antibody Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Anti-CD133 Antibody by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Anti-CD133 Antibody Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Anti-CD133 Antibody Markets in 2023
    Figure 27. United States VS China: Anti-CD133 Antibody Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Anti-CD133 Antibody Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Anti-CD133 Antibody Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Anti-CD133 Antibody Market Size Market Share by Type in 2023
    Figure 31. Monoclonal Antibody
    Figure 32. Polyclonal Antibody
    Figure 33. World Anti-CD133 Antibody Market Size Market Share by Type (2019-2030)
    Figure 34. World Anti-CD133 Antibody Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Anti-CD133 Antibody Market Size Market Share by Application in 2023
    Figure 36. Biotechnology
    Figure 37. Medical
    Figure 38. University
    Figure 39. Others
    Figure 40. Anti-CD133 Antibody Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

BosterBio
GeneTex
ProSci
Bioss
Absolute Antibody
MyBioSource
Biorbyt
Thermo Fisher Scientific
R&D Systems
Novus Biologicals
BioLegend
G Biosciences
Cell Signaling Technology
RayBiotech
HUABIO
Abeomics
Proteintech Group
Miltenyi Biotec
Wuhan Fine Biotech
NSJ Bioreagents
Bethyl Laboratories
OriGene Technologies
Signalway Antibody
Abnova
Bioassay Technology Laboratory
AAT Bioquest
Sino Biological
ProteoGenix